Current knowledge on cellular interactions in the WG-granuloma

Clinical and Experimental Rheumatology

Volumn 25, Issue 1 SUPPL. 44, 2007, Pages

  Lamprecht, Peter ^a   Gross, Wolfgang L ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

ANCA; Autoimmunity; Granuloma; Lymphiod neoformation; Proteinase 3; Wegener's granulomatosis

Indexed keywords

HLA DP ANTIGEN; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEINASE ACTIVATED RECEPTOR 3;

ANTIBODY RESPONSE; ANTIGEN PRESENTING CELL; AUTOIMMUNITY; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL INTERACTION; CELL MATURATION; CELLULAR IMMUNITY; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; EFFECTOR CELL; GENETIC PREDISPOSITION; GENETIC RISK; IMMUNOLOGICAL TOLERANCE; INFLAMMATORY DISEASE; LUNG GRANULOMATOSIS; MEMORY T LYMPHOCYTE; MONOCYTE; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PLASMA CELL; PRIORITY JOURNAL; SHORT SURVEY; SYSTEMIC VASCULITIS; TH1 CELL; UPPER RESPIRATORY TRACT; VASCULAR ENDOTHELIUM; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIGENS, CD28; AUTOANTIGENS; AUTOIMMUNITY; CELL COMMUNICATION; GRANULOMA; HUMANS; MYELOBLASTIN; SELF TOLERANCE; WEGENER GRANULOMATOSIS;

EID: 34247516435     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (16)

1. BACON PA: The spectrum of Wegener's granulomatosis and disease relapse. New Engl J Med 2005; 352: 330-2.
2. HEERINGA P, HUUGEN D, COHEN TERVAERT JW: Anti-neutrophil cytoplasmic autoantibodies and leukocyte-endothelial interactions: a sticky connection? Trends Immunol 2005; 26: 561-4.
3. LU X, GARFIELD A, RAINGER GE, SAVAGE CO, NASH GB: Mediation of endothelial cell damage by serine proteases, but not superoxide, released from antineutrophil cytoplasmic antibody-stimulated neutrophils. Arthritis Rheum 2006; 54: 1619-28.
4. SARRAF P, SNELLER M: Pathogenesis of Wegener's granulomatosis: Current concepts. Expert Rev Mol Med 2005; 7: 1-19.
5. FIENBERG R: A morphologic and immunohistologic study of the evolution of the necrotizing palisading granuloma of pathergic (Wegener's) Granulomatosis. Semin Resp Med 1989; 10: 126-32.
6. KRADIN RL, MARK EJ: Case records of the Massachusetts General Hospital: Weekly clnicopathological exercises. Case 18-2002, A 48-year-old man with a cough and bloody sputum. New Engl J Med 2002; 346: 1892-9.
7. LANG KS, RECHER M, JUNT T et al.: Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 2005; 11: 138-45.
8. ZINKERNAGEL RM: Antiinfection immunity and autoimmunity. Ann N Y Acad Sci 2002; 958: 3-6.
9. - T-cells are a major source of IFN-γ and TNF-α in Wegerner's granulomatosis. Am J Pathol 2002; 160: 1717-24.
10. VOSWINKEL J, MUELLER A, KRAEMER JA et al.: B lymphocyte maturation in Wegener's granulomatosis: a comparative analysis of VH genes from endonasal lesions. Ann Rheum Dis 2006; 65: 859-64.
11. CSERNOK E, AI M, GROSS WL et al.: Wegener's autoantigen induces maturation of dendritic cells and licences them for Th1 priming via the protease-activated receptor-2 pathway. Blood 2006; 107: 4440-8.
12. JAGIELLO P, GROSS WL, EPPLEN J: Complex genetics of Wegener's granulomatosis. Autoimmun Rev 2005; 4: 42-7.
13. POPA ER, STEGEMAN CA, KALLENBERG CGM, COHEN TERVAERT JW: Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2002; 4: 77-9.
14. PENDERGRAFT III WF, PRESTON GA, SHAH RS et al.: Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase 3. Nat Med 2004; 10: 72-79.
15. NOVICK D, RUBINSTEIN M, AZAM T, RABINKOV A, DINARELLO CA, KIM SH: Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA 2006; 103: 3316-21.
16. LAMPRECHT P, CSERNOK E, GROSS WL: Effector memory T-cells as driving force of granuloma formation and autoimmunity in Wegener's granulomatosis. J Intern Med 2006; 260: 187-91.